These exosomes were created by merging genetically engineered exosomes carrying CD47 from tumor cells with those from M1 macrophages, encapsulating them with a DNA-targeting agent (SN38) and a STING agonist (MnO2) (124). This evidence concerns the gene STING1 and neoplasm.